Studies associated with ontology term
MP:0005378   'growth/size/body region phenotype'    
Navigate ontologies  


Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Ackert1 body size and weight Body weight, body length, body mass index. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Ackert1 DXA Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Ankra-Badu1 study archive Body, organ, fat pad weights, weight gain, litter size. QTL population both 2-10wks 2009
Attie2 body weight
with high-fat high-sucrose diet 		Weekly. DO population both 4-26wks 2018
Auwerx1 body weight
with high-fat diet 		8-29 wks of age. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 NMR
with high-fat diet 		Body composition. BXD w/par   (57) m 8-29 wks 2016
Auwerx2 body weight
with high-fat diet 		inbred w/CC8 both 8-21 wks 2021
Bachmanov1 body weight Body weight inbred   (13) m 7-8wks 2011
Bautz1 study archive Plasma lipids. Cholesterol, triglycerides. QTL population both 12-14wks 2013
Beamer2 study archive Bone morphology and strength, insulin-like growth factor 1. QTL population f 16wks 2001
Bennett1 body weight Body weight and growth curve from 4wks to 26wks weighed monthly. ILSXISS   (97) f 6wks 2005
Bennett4 body weight Body weight both 8-20wks 2021
Bennett4 MRI Body composition (lean, fat, water). both 8-20wks 2021
Boon1 body weight
with influenza A (H5N1) virus 		Influenza A (H5N1) virus (several doses) vs. baseline. inbred   (23) f 6-9wks 2011
Brinkmeyer1 body weight
with Theiler's murine encephalomyelitis virus 		Body weight CC   (5) both 4wks 2017
Brockmann1 study archive Body, organ weights, litter size, abdominal fat, lipids, insulin, leptin. QTL population both 3-6wks 2009
Burke1 study archive Femur and vertebra morphology and strength. Monthly body weight 3 - 13 months. QTL population f 14-56wks 2012
CGDpheno1 DXA Body mass, fat mass, lean mass, bone mineral density. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 body size and weight Body weight and length. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno3 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 body weight Body weight CC diallel w/par   (62) both 8-16wks 2012
Chesler2 body size and weight Body weight, body length, tail length. CC diallel w/par   (62) both 7-15wks 2011
Chesler3 body size and weight Body weight, tail length. CC pre w/par   (367) both 7-15wks 2011
Chesler4 body weight Body weight DO population w/par   (9) both 12-16wks 2013
Chesler6 study archive
with ethanol 		Sensitivity to ethanol. Baseline and ethanol. QTL population both 9-34wks 2012
Cheverud1 body weight
with high-fat diet 		Body weight and growth curve from age 1wk to 22wks (pre-wean, post-wean, adult). High-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Churchill1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. F1 8way   (63) both 7-8wks 2004
Churchill1 organ dimensions Ear length (pinal). F1 8way   (63) both 7-8wks 2004
Crabbe1 body weight
with ethanol 		Body weight inbred   (8) both 8wks 2003
Crowley1 body weight
with haloperidol 		Baseline vs. after haloperidol 60d implant. inbred w/CC8   (27) m 9-28wks 2012
Crusio1 body weight Body weight BXD w/par   (55) both 10-16wks 2018
Deschepper1 body weight Body weight inbred   (13) both 10wks 2004
DiCurzio1 body weight Body weight BXD w/par   (66) both 10wks 2010
Donahue1 DXA Body mass, fat mass, lean mass, bone mineral density and content, craniofacial dimensions. inbred w/CC7   (30) both 15-16wks 2002
Donahue16 DXA Body mass, fat mass, bone mineral density. B6.A consomic w/par   (23) both 24-29wks 2012
Donahue18 body weight Pup body weight at day 3. inbred   (15) f 6-8wks 2010
Donahue19 body weight Pup body weight at day 3. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue2 body weight Body weight inbred   (10) both 16wks 2004
Doorenbos1 study archive Urinalysis. Creatinine, microalbumin, body weight. QTL population m 8-10wks 2008
Dzur-Gejdosova1 study archive Sterility investigation. Sperm count, testes weight. QTL population m 9wks 2012
Eumorphia2 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred   (5) both 12, 24, 52 wks 2008
Everett1 body weight Body weight inbred   (14) both 9-12wks 2003
Evsikova1 body weight Body weight inbred   (14) both 25wks 2009
Farmer1 study archive Colitis susceptibility, severity. Colon histopathology, body and spleen weight. QTL population both 6wks 2001
Feng1 study archive Blood pressure (tail cuff), kidney weight, body weight. QTL population m 8wks 2009
Ferris1 body weight
with influenza A (H1N1) virus 		Body weight CC pre w/par   (163) f 8-16wks 2012
GMC10 NMR Body mass, fat and lean tissue mass. inbred w/CC8   (8) both 12-13, 18-19wks 2020
GMC18 body size and weight Body weight and length. inbred w/CC8   (8) both 17-18wks 2020
GMC18 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred w/CC8   (8) both 17-18wks 2020
Graham1 body weight
with West Nile virus 		Body weight CC RIX   (5) m 8-10wks 2015
Graham2 colony observation
with SARS-CoV 		Body weight loss and mortality. CC RIX   (117) f 8-10wks 2021
Guay-Woodford1 study archive Kidney morphology, renal cystic disease severity. QTL population f 2wks 2000
Gupta1 body weight Body weight of newborns. inbred   (8) both postnatal 2011
Gupta2 body weight Body weight of newborns. BXH   (10) both postnatal 2011
Hadsell1 body weight Daily body weight gain of cross-fostered pups. inbred   (31) f 14-18wks 2012
Hallgrimsson1 body weight Body weight DO population both 8-60 wks 2020
Hallgrimsson1 bone dimensions 3D, craniofacial landmark coordinates based on centroid. DO population both 8-60 wks 2020
Handel1 body weight Body weight inbred   (14) m 8-10wks 2010
Harrill1 body weight
with isoniazid 		Body weight. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill2 body weight
with DB289 		DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Ishimori1 study archive
with high-fat diet 		Lipids, atherosclerosis lesions, parathyroid hormone after high-fat diet. QTL population f 20wks 2004
Jax1 body weight Body weight and growth curve from age 3wks to 10 wks, weighed weekly. inbred   (24) both 8wks 2000
JaxCC1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC   (18) both various 2018
JaxKOMP-EAP observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). KOMP both 8-18wks 2021
JaxKOMP-EAP X-ray Counts of vertebrae, ribs, digits, and other categorical parameters. KOMP both 8-18wks 2021
JaxKOMP-EAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 8-18wks 2021
JaxKOMP-LAP observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). KOMP both 66-81wks 2021
JaxKOMP-LAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 66-81wks 2021
Jaxpheno1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred   (11) both 8, 16 wks 2006
Jaxpheno1 body weight Body weight inbred   (11) both 8, 16 wks 2006
Jaxpheno2 body weight Body weight inbred   (11) both 8, 16 wks 2006
Jaxpheno5 body weight Body weight and growth curve from age 3wks to 16wks, weighed weekly. inbred   (10) both 3-16wks 2014
Jaxpheno6 body weight Body weight inbred   (11) both 8, 16 wks 2006
Jaxwest1 body weight Body weight inbred   (7) both 8-14wks 2003
Jaxwest1 DXA Body mass, fat mass, lean mass, bone mineral density and content (whole body, femur, spine). inbred   (7) both 8-14wks 2003
Karst1 study archive Characterization of high-muscle-mass mice. QTL population both 3-10wks 2011
Kim1 study archive Glucose, insulin, body and fat pad weights. QTL population m 20-26wks 2001
Kumar1 study archive
with cocaine 		Open field test. Locomotor, anxiety-related, circadian behavior. Baseline and after cocaine i.p. QTL population both 10-14wks 2014
Kumar3 body weight Body weight inbred w/CC8   (62) both 8-14wks 2021
Kumar4 body size and weight Body length measurements. inbred w/CC8   (62) both 10-20 wks 2021
Leiter2 study archive Type 1 diabetes development study. QTL population f 14-40wks 2009
Levy1 body weight Body weight CC pre   (31) both 8-14wks 2015
Li1 study archive
with western diet 		Lipids, atherosclerosis lesion histopathology. High-fat, western-style diet. QTL population f 12wks 2008
Lightfoot1 body weight Body weight inbred   (41) both 8-9wks 2010
Lionikas1 body weight
with exercise 		Exercise (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Mao1 body weight Body weight CC   (16) both 10wks 2015
Massett1 body weight Body weight inbred   (34) both 8wks 2012
Mathes1 body weight
with exercise 		Baseline vs. after exercise (access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Maurer1 body weight
with atenolol, isoproterenol 		Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
McMullan1 MRI Body composition (fat and lean mass and percent). CC   (50) f 17-72wks 2017
McMullan3 body weight Body weight before, during, and after several weeks of exercise. CC   (43) f 20-88wks 2017
McMullan3 MRI Body composition (fat and lean mass) before, during, and after several weeks of exercise. CC   (43) f 20-88wks 2017
McMullan4 body weight
with exercise 		Body weight before and after 2 weeks of exercise wheel availability. CC   (13) f 32-40wks 2018
McMullan4 MRI
with exercise 		Body composition (fat and lean mass) before and after 2 weeks of exercise wheel availability. CC   (13) f 32-40wks 2018
McMullan6 body weight
with exercise 		Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. CC   (4) both 8-10wks 2018
McMullan6 MRI
with exercise 		Body composition (fat and lean mass) before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. CC   (4) both 8-10wks 2018
Metten2 body weight
with ethanol 		Body weight inbred   (15) m 8-11wks 2005
Molenhuis1 body weight Body weight CC   (52) m 7-20wks 2018
Morgan1 body weight
with high-fat diet and olanzapine 		Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). inbred w/CC8   (9) f 8-18wks 2014
Mrug1 study archive Kidney morphology. QTL population both 1-2wks 2005
Nadeau1 body weight
with high-fat diet 		Baseline vs. high-fat diet for 12wks. B6.A consomic w/par   (24) m 5, 17 wks 2008
Nadeau2 body size and weight
with high-fat high-sucrose diet 		Body weight, size, and body mass index after 16wks on high-fat high-sucrose diet. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau3 body weight
with high-fat high-sucrose diet 		After 16 wks on high-fat high-sucrose diet. inbred   (2) m 21 wks 2016
Nadeau3 body size and weight
with high-fat high-sucrose diet 		Body weight and body mass index after 16 wks of high-fat high-sucrose diet. inbred   (2) m 21 wks 2016
Nadeau4 body weight
with high-fat high-sucrose diet 		High-fat high-sucrose diet for 14-15 wks B6.A consomic w/par   (3) m 4-19 wks 2016
Nadeau4 body size and weight
with high-fat high-sucrose diet 		Body length and body mass index after high-fat high-sucrose diet for 14-15 wks B6.A consomic w/par   (3) m 4-19 wks 2016
Naggert1 body weight
with high-fat diet 		High-fat diet for 8wks. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 DXA
with high-fat diet 		Body mass, fat mass, lean mass, bone mineral density and content after 8wks on high-fat diet. inbred w/CC7   (43) both 5, 21 wks 2003
Nelson1 body weight
with restricted diet 		Restricted diet vs. ad libitum diet. ILSXISS   (44) both max lifespan 2010
Nelson1 NMR
with restricted diet 		Body mass, fat mass, lean mass. Restricted diet vs. ad libitum diet. ILSXISS   (44) both max lifespan 2010
Odet1 body weight Body weight inbred   (8) m 10-66wks 2015
Paigen1 body weight
with high-fat diet 		Baseline vs. high-fat diet for 8wks. inbred   (44) both 15-19wks 2000
Paigen3 body weight
with high-fat diet 		Baseline vs. high-fat diet for 8wks. obesity mutants   (8) both 15-19wks 2000
Palmer3 body weight Body weight F1 Tcf7l2   (30) both 7-14wks 2017
Palmer4 body weight
with methamphetamine 		Body weight F1 Cacna1c   (30) both 7-14wks 2017
Palmer5 body weight Body weight F1 Tcf7l2   (30) both 7-14wks 2017
Palmer6 body weight
with methamphetamine 		Body weight F1 Cacna1c   (30) both 7-14wks 2017
Payseur1 study archive Body weight of Gough Island mice. QTL population both 1-16wks 2015
Peters5 study archive Complete blood count measures on fetuses, newborns. QTL population both fetus, newborn 2004
Pletcher1 body weight Body weight inbred   (32) m 7-9wks 2007
Reed1 body size and weight Body weight, body length, body mass index. inbred   (28) m 8, 12 wks 2009
Reed2 body size and weight Body weight, body length, body mass index. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reed2 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. High-fat diet vs. control. Two age cohorts. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reifsnyder1 study archive Body weight (several ages), fat mass, body mass index, fat pad weights. QTL population m 4-24wks 2000
Rhodes1 body weight
with exercise 		Exercise wheel group vs. control group. inbred   (12) both 8-15wks 2010
Richards-Smith1 study archive
with macronutrient diet option 		Caloric intake, glucose, body and fat pad weights. Macronutrient diet option. QTL population m 8-13wks 2002
RIKEN-EAD1 body size and weight Body weight, body length, tail length. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD2 body size and weight Body weight, body length, tail length. wild-derived RBRC   (33) both 8, 12 wks 2008
Schoenrock1 body weight
with various diets 		Body weight at weaning and time of test. Comparison of 4 diets. CC RIX   (18) f 8-9 wks 2018
Schonfeld1 body weight Body weight inbred   (11) both 8-10wks 2005
Schoonjans1 body weight
with high-fat diet 		At 8, 20 and 29 wks of age. BXD w/par   (36) m 8-29 wks 2022
Schughart1 body weight
with influenza A (H1N1) virus 		Influenza A (H1N1) virus vs. baseline. Several timepoints. inbred   (9) both 10-12wks 2009
Schughart2 body weight
with influenza A (H1N1) virus 		Influenza A (H1N1) virus vs. baseline. Several timepoints.. BXD w/par   (56) f 9-18wks 2012
Schughart3 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. inbred w/CC8   (8) both 7-13wks 2013
Schughart4 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schughart5 body weight
with influenza A (H3N2) virus 		Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schulz1 body weight Body weight inbred   (7) both 9-18wks 2000
Seburn1 body weight Body weight inbred   (16) both 7-9wks 2001
Shockley1 body weight
with high-fat diet 		High-fat diet for 4wks vs. control. inbred   (10) both 10-13wks 2008
Shorter4 body weight Body weight CC   (12) m 15-33wks 2020
Shorter5 body weight Body weight CC RIX   (28) m 7-44wks 2020
Shorter8 body weight Body weight DO population m 12-15wks 2020
Solberg1 study archive Open field test, forced swim test, defensive burying task. QTL population both 11-17wks 2004
Stylianou1 study archive
with high-fat diet 		Body size, weight, fat pad weights after high-fat diet. QTL population both 24wks 2006
Stylianou2 study archive Lipids. Cholesterol, triglycerides, body weight. QTL population both 8-10wks 2006
Su2 study archive
with high-fat diet 		Lipids (plasma). Cholesterol, triglycerides, aortic lesions, body mass index. QTL population f 14wks 2009
Sugiyama3 study archive Blood pressure (tail cuff), heart weight, body weight. QTL population m 10wks 2002
Sunde1 body weight
with selenium 		Body weight curve 3 to 12 wks, control group. inbred w/CC8   (8) m 3-14wks 2018
Svenson4 body size and weight Body weight, body length, body mass index. B6.PWD consomic w/par   (28) both 16wks 2006
Svenson4 DXA Body mass, fat mass, lean mass, bone mineral density and content. B6.PWD consomic w/par   (28) both 16wks 2006
Tarantino1 body weight
with cocaine 		Body weight inbred   (45) m 8-11wks 2015
Tordoff2 body weight Body weight inbred   (28) m 4-12wks 2001
Tordoff3 body weight Body weight inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred w/CC7   (40) both 9-15wks 2002
Tsaih1 study archive Brain weight, body weight. QTL population both 2005
Vanderlinden1 body weight Body weight ILSXISS   (43) both 8-23wks 2015
Vinyard1 body weight Body weight inbred   (21) both 6-8wks 2009
Willott1 body weight Body weight inbred w/CC7   (40) both 5-6wks 2002
Wittenburg1 study archive
with high-fat diet 		Liver weight, gallbladder and gallstone histopathology. QTL population both 18-20wks 2002
Wittenburg2 study archive
with high-fat diet 		Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 6-16wks 2003
Wittenburg3 study archive
with high-fat diet 		Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 2005
Xenakis1 body weight Body weight CC RIX   (73) both 7-13wks 2020
Xenakis2 body weight
with arsenic 		Baseline, then after iAs exposure for 26 wks DO population m 4-34 wks 2022
Xenakis2 MRI
with arsenic 		Fat and lean tissue mass at baseline, and 12 and 24 wks after iAs exposure DO population m 4-34 wks 2022
Yi1 study archive Body weight (several timepoints) and liver weight. QTL population both 2-12wks 2007
Yuan1 body weight Aging study, 6mo, 12mo, and 18mo. inbred   (33) both 26, 52, 78 wks 2007
Zhang1 study archive
with western diet 		Atherosclerosis and glucose homeostasis. Lesions, lipids, glucose, insulin. High-fat, western-style diet. QTL population f <6-18wks 2012
Zheng1 tympanometry Middle ear function. inbred   (61) both 15-51d 2008
Zimmermann1 body weight inbred   (30) both 7-15 wks 2020